BRAF and thyroid gland carcinoma: Adjuvant therapy may include radiotherapy, chemotherapy, or targeted therapy, wherein radiotherapy is primarily used to control local lesions, chemotherapy is used for potentially small metastatic lesions or identified distant metastases, and targeted therapy for thyroid cancers with specific molecular markers, such as papillary thyroid cancer with BRAF mutation (20).